Stallion India Fluorochemicals Monitoring Agency Reports Rights Issue Utilisation for Q2 FY2027
Infomerics Valuation confirms payments within project estimates amid ongoing advance payments to EPC contractor up to Rs. 78 crore
Stallion India Fluorochemicals Limited's Monitoring Agency Infomerics reports on the utilisation of Rs. 363.93 crore Rights Issue proceeds for Q2 FY2027 ending September 30, 2026. Payments to EPC contractor Pansen Engineering India Pvt Ltd totaling Rs. 78 crore remain within the estimated project budget of Rs. 269.76 crore. No deviations or approvals pending were noted.
Stallion India Fluorochemicals Limited
Preferential Issue
Stallion India Fluorochemicals Limited's monitoring agency, Infomerics Valuation and Rating Limited, has submitted its report confirming the utilisation of proceeds from the company's Rs. 363.93 crore Rights Issue for the quarter ended September 30, 2026.
The monitoring report addresses the deployment of funds raised through the Rights Issue opened on February 20, 2026, and closed on February 27, 2026.
Payments totaling Rs. 78 crore made in advance to Pansen Engineering India Pvt Ltd, the EPC contractor for civil works, fall within the total estimated contract amount of Rs. 269.76 crore disclosed in the Rights Issue document.
Payments are made on an advance basis before invoices are raised on completion of specific structures; hence the monitoring agency could not verify alignment with individual invoices but confirmed consistency with party ledgers and bank statements.
The monitoring agency did not find any material deviations from the objectives stated in the Rights Issue and confirmed that all statutory approvals related to the issue proceeds had been obtained.
The report declares no conflicts of interest or direct relationships between the monitoring agency and the company or its promoters.
Highlights
- Rights Issue size confirmed at Rs. 363.93 crore with 3,67,60,483 equity shares issued at Rs. 99 each.
- Advance payments to EPC contractor Pansen Engineering India Pvt Ltd totaled Rs. 78 crore for Q2 FY2027, within the total Rs. 269.76 crore contract estimate.
- No material deviations or changes to utilisation plan disclosed in the Issue Document observed during the quarter.
- Infomerics confirms receipt of all necessary regulatory and statutory approvals related to the utilisation of issue proceeds.
- Monitoring agency report dated November 14, 2026, under SEBI ICDR Regulations for the quarter ended September 30, 2026.
Key Data Snapshot
What happened
- Monitoring agency Infomerics Valuation and Rating Limited completed its review of Stallion India Fluorochemicals Limited’s utilisation of proceeds from the Rs. 363.93 crore Rights Issue for Q2 FY2027 ending September 30, 2026.
- The report covers progress and fund allocation in accordance with the Securities and Exchange Board of India (SEBI) ICDR Regulations.
- Payments to EPC contractor Pansen Engineering India Pvt Ltd during the quarter amounted to Rs. 78 crore in advances for civil work related to project structures.
Key details
- Rights Issue launched from February 20 to February 27, 2026, issuing 3,67,60,483 equity shares at Rs. 99 per share.
- Pansen Engineering India Pvt Ltd serves as the EPC contractor for civil works under a contract estimated at Rs. 269.76 crore.
- Payments made are advances; invoices raised only after specific project components are completed.
- Monitoring Agency was unable to verify full contract scope or invoice-payment matching due to partial contract disclosure.
- No material deviations from the Rights Issue objectives noted; statutory approvals for the project are in place.
Regulatory and governance context
- Report prepared under SEBI ICDR Regulations 2018 concerning issue proceeds monitoring.
- The monitoring agency affirms no conflicts of interest or direct relationships with Stallion India Fluorochemicals Limited or its promoters.
- The agency clarifies the report is not an audit but based on information deemed accurate and reliable.
- The report was submitted on November 14, 2026.
Highlights
- Rights Issue size confirmed at Rs. 363.93 crore with 3,67,60,483 equity shares issued at Rs. 99 each.
- Advance payments to EPC contractor Pansen Engineering India Pvt Ltd totaled Rs. 78 crore for Q2 FY2027, within the total Rs. 269.76 crore contract estimate.
- No material deviations or changes to utilisation plan disclosed in the Issue Document observed during the quarter.
- Infomerics confirms receipt of all necessary regulatory and statutory approvals related to the utilisation of issue proceeds.
- Monitoring agency report dated November 14, 2026, under SEBI ICDR Regulations for the quarter ended September 30, 2026.
Disclosures
- Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018
- Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on Preferential Issue
View allLatest corporate announcements and market updates in Preferential Issue.
KP Green Engineering Boards ₹99.99 Crore Preferential Issue of Equity Warrants to Promoter
KP Green Engineering Limited's Board has approved a preferential issue of up to 34,24,657 fully convertible equity warrants priced at ₹292 each to promoter Dr. Faruk G. Patel, potentially raising ₹99.99 crore pending shareholder and regulatory approvals.
Read Full StoryYuken India Utilizes ₹5,991.84 Lakhs Raised from Preferential Allotment Fully as Planned by September 2026
Yuken India Limited has confirmed that ₹5,991.84 lakhs raised through a preferential allotment conducted on July 24, 2025, to its promoter Yuken Kogyo Co. Ltd, Japan, have been utilized exactly as intended for business expansion and commencing manufacturing of new products by September 30, 2026.
Read Full StoryFischer Medical Ventures Raises Rs. 358.45 Crore via Preferential Share Issue and Warrants Conversion
Fischer Medical Ventures Limited successfully raised Rs. 358.45 crore through a preferential allotment of equity shares and conversion of fully convertible warrants by September 30, 2026, with full compliance to the issuance objectives and no financial deviations.
Read Full Story